Skip to main content
. 2022 Sep 26;13:988130. doi: 10.3389/fimmu.2022.988130

Figure 7.

Figure 7

m6A modifies the tumor immune microenvironment and regulates tumor progression. m6A writers, erasers and readers regulate the tumor immune microenvironment in glioma, liver cancer, colorectal cancer, esophageal cancer, pancreatic cancer, lung cancer, breast cancer, and bladder cancer by controlling different immune cells and the PD-1/PD-L1 immune checkpoint mediating the efficacy of immune therapy.